These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24483782)

  • 1. New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer.
    Chiaradonna F; Cirulli C; Palorini R; Votta G; Alberghina L
    Antioxid Redox Signal; 2015 Jul; 23(1):30-50. PubMed ID: 24483782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
    Yoshida M; Shimazu T; Matsuyama A
    Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy.
    Botrugno OA; Robert T; Vanoli F; Foiani M; Minucci S
    Clin Cancer Res; 2012 May; 18(9):2436-42. PubMed ID: 22512979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.
    Parbin S; Kar S; Shilpi A; Sengupta D; Deb M; Rath SK; Patra SK
    J Histochem Cytochem; 2014 Jan; 62(1):11-33. PubMed ID: 24051359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy.
    Stengel KR; Hiebert SW
    Antioxid Redox Signal; 2015 Jul; 23(1):51-65. PubMed ID: 24730655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylases--an important class of cellular regulators with a variety of functions.
    Hildmann C; Riester D; Schwienhorst A
    Appl Microbiol Biotechnol; 2007 Jun; 75(3):487-97. PubMed ID: 17377789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of histone deacetylases (HDACs) in UPR regulation.
    Kahali S; Sarcar B; Chinnaiyan P
    Methods Enzymol; 2011; 490():159-74. PubMed ID: 21266250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear histone deacetylases are not required for global histone deacetylation during meiotic maturation in porcine oocytes.
    Endo T; Kano K; Naito K
    Biol Reprod; 2008 Jun; 78(6):1073-80. PubMed ID: 18305223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assay for inhibitory activity of histone deacetylase].
    Yoshida M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
    Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors and cancer: from cell biology to the clinic.
    Hess-Stumpp H
    Eur J Cell Biol; 2005 Mar; 84(2-3):109-21. PubMed ID: 15819394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis.
    Chen PJ; Huang C; Meng XM; Li J
    Biochimie; 2015 Sep; 116():61-9. PubMed ID: 26116886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation of proteins as novel target for antitumor therapy: review article.
    Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
    Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of pyridone-based histone deacetylase inhibitors: approaches for metabolic stability.
    Cho M; Choi E; Yang JS; Lee C; Seo JJ; Kim BS; Oh SJ; Kim HM; Lee K; Park SK; Kwon HJ; Han G
    ChemMedChem; 2013 Feb; 8(2):272-9. PubMed ID: 23292995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential for HDAC inhibitors in the heart.
    McKinsey TA
    Annu Rev Pharmacol Toxicol; 2012; 52():303-19. PubMed ID: 21942627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment.
    Weidle UH; Grossmann A
    Anticancer Res; 2000; 20(3A):1471-85. PubMed ID: 10928059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylases as targets for treatment of multiple diseases.
    Tang J; Yan H; Zhuang S
    Clin Sci (Lond); 2013 Jun; 124(11):651-62. PubMed ID: 23414309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors merged with protein tyrosine kinase inhibitors.
    Zhou N; Xu W; Zhang Y
    Drug Discov Ther; 2015 Jun; 9(3):147-55. PubMed ID: 26193935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of histone deacetylation: a strategy for tumor radiosensitization.
    Camphausen K; Tofilon PJ
    J Clin Oncol; 2007 Sep; 25(26):4051-6. PubMed ID: 17827453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.